B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Price:
8.75
HKD
0.92%
Market Cap:
7.3B
HKD
Income Statement
Earnings Waterfall
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Beijing Tong Ren Tang Chinese Medicine Co Ltd
|
Revenue
|
1.4B
HKD
|
|
Cost of Revenue
|
-384.7m
HKD
|
|
Gross Profit
|
992m
HKD
|
|
Operating Expenses
|
-439m
HKD
|
|
Operating Income
|
553m
HKD
|
|
Other Expenses
|
-58.9m
HKD
|
|
Net Income
|
494.1m
HKD
|
Income Statement
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Currency: HKD
Millions
TTM
| Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Revenue |
614
N/A
|
652
+6%
|
699
+7%
|
733
+5%
|
761
+4%
|
834
+10%
|
881
+6%
|
939
+7%
|
970
+3%
|
1 002
+3%
|
1 028
+3%
|
1 063
+3%
|
1 084
+2%
|
1 134
+5%
|
1 166
+3%
|
1 212
+4%
|
1 266
+4%
|
1 330
+5%
|
1 402
+5%
|
1 514
+8%
|
2 336
+54%
|
1 433
-39%
|
1 178
-18%
|
1 315
+12%
|
1 452
+10%
|
1 556
+7%
|
1 478
-5%
|
1 731
+17%
|
1 918
+11%
|
1 525
-20%
|
1 377
-10%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||
| Cost of Revenue |
(194)
|
(203)
|
(217)
|
(223)
|
(218)
|
(252)
|
(264)
|
(283)
|
(290)
|
(280)
|
(276)
|
(280)
|
(289)
|
(297)
|
(311)
|
(331)
|
(350)
|
(368)
|
(397)
|
(435)
|
(657)
|
(420)
|
(376)
|
(362)
|
(388)
|
(437)
|
(427)
|
(581)
|
(693)
|
(478)
|
(385)
|
|
| Gross Profit |
420
N/A
|
449
+7%
|
482
+7%
|
510
+6%
|
543
+7%
|
583
+7%
|
617
+6%
|
656
+6%
|
681
+4%
|
722
+6%
|
752
+4%
|
784
+4%
|
795
+1%
|
837
+5%
|
855
+2%
|
881
+3%
|
916
+4%
|
963
+5%
|
1 004
+4%
|
1 078
+7%
|
1 679
+56%
|
1 013
-40%
|
802
-21%
|
953
+19%
|
1 064
+12%
|
1 120
+5%
|
1 052
-6%
|
1 150
+9%
|
1 225
+6%
|
1 047
-14%
|
992
-5%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(156)
|
(148)
|
(166)
|
(172)
|
(200)
|
(214)
|
(224)
|
(235)
|
(228)
|
(236)
|
(232)
|
(241)
|
(268)
|
(281)
|
(300)
|
(308)
|
(319)
|
(340)
|
(344)
|
(380)
|
(557)
|
(361)
|
(306)
|
(284)
|
(314)
|
(341)
|
(329)
|
(339)
|
(375)
|
(429)
|
(439)
|
|
| Selling, General & Administrative |
(170)
|
(166)
|
(167)
|
(173)
|
(201)
|
(216)
|
(226)
|
(236)
|
(232)
|
(239)
|
(238)
|
(247)
|
(272)
|
(284)
|
(301)
|
(309)
|
(321)
|
(342)
|
(347)
|
(381)
|
(559)
|
(364)
|
(317)
|
(296)
|
(334)
|
(341)
|
(337)
|
(284)
|
(384)
|
(360)
|
(448)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
0
|
(8)
|
0
|
(64)
|
0
|
(71)
|
0
|
|
| Other Operating Expenses |
13
|
18
|
2
|
2
|
1
|
1
|
1
|
1
|
4
|
4
|
5
|
5
|
4
|
4
|
2
|
3
|
2
|
2
|
2
|
1
|
2
|
3
|
11
|
24
|
19
|
8
|
8
|
10
|
9
|
3
|
9
|
|
| Operating Income |
264
N/A
|
301
+14%
|
317
+5%
|
338
+7%
|
344
+2%
|
368
+7%
|
393
+7%
|
422
+7%
|
452
+7%
|
486
+7%
|
520
+7%
|
542
+4%
|
527
-3%
|
556
+5%
|
555
0%
|
574
+3%
|
598
+4%
|
623
+4%
|
660
+6%
|
698
+6%
|
1 122
+61%
|
652
-42%
|
495
-24%
|
669
+35%
|
750
+12%
|
778
+4%
|
723
-7%
|
812
+12%
|
850
+5%
|
618
-27%
|
553
-11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
3
|
6
|
9
|
11
|
12
|
12
|
12
|
9
|
4
|
3
|
2
|
3
|
6
|
8
|
9
|
12
|
13
|
14
|
14
|
23
|
42
|
37
|
29
|
16
|
6
|
(0)
|
(4)
|
14
|
42
|
67
|
64
|
|
| Non-Reccuring Items |
5
|
0
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Other Income |
0
|
(0)
|
(2)
|
(2)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
272
N/A
|
307
+13%
|
330
+7%
|
354
+7%
|
355
+0%
|
380
+7%
|
404
+6%
|
431
+7%
|
457
+6%
|
489
+7%
|
522
+7%
|
545
+4%
|
532
-2%
|
564
+6%
|
565
+0%
|
586
+4%
|
611
+4%
|
636
+4%
|
674
+6%
|
721
+7%
|
1 164
+61%
|
689
-41%
|
525
-24%
|
686
+31%
|
756
+10%
|
778
+3%
|
719
-8%
|
826
+15%
|
892
+8%
|
688
-23%
|
617
-10%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
(44)
|
(50)
|
(54)
|
(59)
|
(61)
|
(66)
|
(72)
|
(79)
|
(82)
|
(88)
|
(91)
|
(94)
|
(92)
|
(100)
|
(98)
|
(99)
|
(105)
|
(104)
|
(116)
|
(120)
|
(192)
|
(112)
|
(82)
|
(118)
|
(133)
|
(127)
|
(120)
|
(135)
|
(141)
|
(97)
|
(84)
|
|
| Income from Continuing Operations |
228
|
257
|
276
|
295
|
295
|
314
|
332
|
352
|
375
|
401
|
431
|
451
|
440
|
464
|
467
|
487
|
506
|
533
|
559
|
601
|
972
|
577
|
442
|
568
|
623
|
652
|
599
|
691
|
751
|
591
|
533
|
|
| Income to Minority Interest |
(8)
|
(8)
|
(9)
|
(9)
|
(8)
|
(10)
|
(13)
|
(15)
|
(20)
|
(21)
|
(21)
|
(20)
|
(20)
|
(19)
|
(18)
|
(18)
|
(16)
|
(16)
|
(18)
|
(21)
|
(33)
|
(21)
|
(18)
|
(25)
|
(39)
|
(44)
|
(44)
|
(45)
|
(54)
|
(50)
|
(39)
|
|
| Net Income (Common) |
220
N/A
|
249
+13%
|
267
+7%
|
286
+7%
|
287
+0%
|
304
+6%
|
320
+5%
|
337
+5%
|
354
+5%
|
380
+7%
|
410
+8%
|
431
+5%
|
420
-2%
|
445
+6%
|
449
+1%
|
469
+4%
|
490
+5%
|
516
+5%
|
540
+5%
|
581
+8%
|
939
+62%
|
556
-41%
|
424
-24%
|
542
+28%
|
583
+7%
|
608
+4%
|
555
-9%
|
646
+16%
|
697
+8%
|
540
-22%
|
494
-9%
|
|
| EPS (Diluted) |
0.26
N/A
|
0.31
+19%
|
0.32
+3%
|
0.34
+6%
|
0.35
+3%
|
0.37
+6%
|
0.39
+5%
|
0.41
+5%
|
0.42
+2%
|
0.46
+10%
|
0.49
+7%
|
0.52
+6%
|
0.5
-4%
|
0.53
+6%
|
0.54
+2%
|
0.56
+4%
|
0.59
+5%
|
0.62
+5%
|
0.65
+5%
|
0.69
+6%
|
1.12
+62%
|
0.66
-41%
|
0.51
-23%
|
0.65
+27%
|
0.7
+8%
|
0.73
+4%
|
0.66
-10%
|
0.77
+17%
|
0.83
+8%
|
0.65
-22%
|
0.59
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
